Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Solid Biosciences Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 116
- −9 vs. Q1 2025
- Shares held
- 82.8M
- +3.63M (+4.6%) vs. Q1 2025
- Total value
- $403.4M
- +$110.2M (+37.6%) vs. Q1 2025
- New holders
- 26
- 55 more added
- Sold out
- 35
- 14 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $717.4M |
| Q4 2025 | 132 | $459.2M |
| Q3 2025 | 129 | $505.2M |
| Q2 2025 | 116 | $403.4M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.8M |
| Q2 2024 | 80 | $213.2M |
| Q1 2024 | 56 | $465.9M |
| Q4 2023 | 40 | $102.2M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $132.2M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $293.4M |
| Q1 2021 | 104 | $437.6M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 1,510,153 | $7.36M | 0.00% | +979,294+184.5% | Added |
| Franklin Resources Inc | 1,599,173 | $7.79M | 0.00% | +358,473+28.9% | Added |
| MPM Oncology Impact Management LP | 1,634,569 | $7.96M | 1.38% | −7,787−0.5% | Reduced |
| Alyeska Investment Group, L.P. | 1,640,821 | $7.99M | 0.03% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,703,336 | $8.30M | 0.59% | +1,421,968+505.4% | Added |
| Redmile Group, LLC | 1,915,926 | $9.33M | 0.99% | −103,245−5.1% | Reduced |
| Monashee Investment Management LLC | 2,165,000 | $10.5M | 5.56% | +491,588+29.4% | Added |
| Citadel Advisors LLC | 2,523,293 | $12.3M | 0.01% | +637,410+33.8% | Added |
| FMR LLC | 3,178,400 | $15.5M | 0.00% | −339,488−9.7% | Reduced |
| Vanguard Group Inc | 3,365,547 | $16.4M | 0.00% | +905,097+36.8% | Added |
| BlackRock, Inc. | 4,920,083 | $24.0M | 0.00% | +2,769,210+128.7% | Added |
| Ra Capital Management, L.P. | 5,811,323 | $28.3M | 0.48% | +1,480,877+34.2% | Added |
| Adage Capital Partners GP, L.L.C. | 6,729,484 | $32.8M | 0.06% | 00.0% | Unchanged |
| Siren, L.L.C. | 7,415,905 | $36.1M | 1.87% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 7,911,669 | $38.5M | 4.82% | 00.0% | Unchanged |
| Perceptive Advisors LLC | 11,906,646 | $58.0M | 2.18% | 00.0% | Unchanged |
| Commodore Capital LP | 0 | $0 | 0.00% | −5,825,000−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −2,481,400−100.0% | Sold out |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −1,240,700−100.0% | Sold out |
| Casdin Capital, LLC | 0 | $0 | 0.00% | −775,000−100.0% | Sold out |
| EcoR1 Capital, LLC | 0 | $0 | 0.00% | −744,450−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −452,239−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −336,325−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −230,000−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −198,150−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −175,400−100.0% | Sold out |
| Trexquant Investment LP | 0 | $0 | 0.00% | −167,031−100.0% | Sold out |
| Resolute Capital Asset Partners LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −105,682−100.0% | Sold out |
| Logos Global Management LP | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −69,874−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −55,229−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −40,987−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −40,930−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −38,226−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −37,325−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −34,479−100.0% | Sold out |
| Allianz Asset Management GmbH | 0 | $0 | 0.00% | −27,100−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −25,742−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −15,051−100.0% | Sold out |
| Corebridge Financial, Inc. | 0 | $0 | 0.00% | −11,643−100.0% | Sold out |
| Ground Swell Capital, LLC | 0 | $0 | 0.00% | −11,223−100.0% | Sold out |
| Ieq Capital, LLC | 0 | $0 | 0.00% | −11,124−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,768−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −2,395−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,992−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,095−100.0% | Sold out |
| Smartleaf Asset Management LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| Coldstream Capital Management Inc | 0 | $0 | 0.00% | −685−100.0% | Sold out |
| GAMMA Investing LLC | 0 | $0 | 0.00% | −153−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −95−100.0% | Sold out |